Mti-107
ClinicalTrials.gov NCT03540160
Research payments
$544,768
Through program year 2021, $544,768 in research payments was reported against Mti-107, across 277 payments, paid by VYNE Pharmaceuticals Inc..
- Paid by
- VYNE Pharmaceuticals Inc.
- ClinicalTrials.gov
- NCT03540160
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $3,089 | 2 |
| 2020 | Research | $541,679 | 275 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Blakely Richardson Austin, TX Named on 15 payments
- Stephen Tyring Webster, TX Named on 10 payments
- Craig Teller Bellaire, TX Named on 10 payments
- Robert Call Richmond, VA Named on 10 payments
- Teresa Sligh Burbank, CA Named on 9 payments
- Sunil Dhawan Fremont, CA Named on 9 payments
- Iftikhar Hussain Tulsa, OK Named on 9 payments
- Rola Gharib Morgantown, WV Named on 9 payments
- Laura Ferris Pittsburgh, PA Named on 9 payments
- Laurie Han-Conrad San Diego, CA Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.